EMA Authorised: Exparel liposomal (bupivacaine) — Pacira Ireland Limited

View source ↗

Summary

The European Medicines Agency has authorised Exparel liposomal (bupivacaine) by Pacira Ireland Limited for use in acute postoperative pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Exparel liposomal (bupivacaine (liposomal formulation))

Snippet

Status: Authorised. Therapeutic area: Acute Pain. MAH: Pacira Ireland Limited. Decision date: 23/07/2025